Evidence map›Paper›PMID 29224371›Full record

ArticleDrug delivery2018

Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity.

Soo-Yeon Kim, Whi-An Kwon, Seung-Pil Shin, Ho Kyung Seo, Soo-Jeong Lim, Yuh-Seog Jung, Hyo-Kyung Han, Kyung-Chae Jeong, Sang-Jin Lee

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Soo-Yeon Kima Immunotherapeutics Branch , Research Institute, National Cancer Center , Goyang , Gyeonggi-do , Korea.
Whi-An Kwonb School of Medicine , Institute of Wonkwang Medical Science, Wonkwang University, Wonkwang Univ. Sanbon Hospital , Sanbon , Korea.
Seung-Pil Shina Immunotherapeutics Branch , Research Institute, National Cancer Center , Goyang , Gyeonggi-do , Korea.
Ho Kyung Seoc Biomarker Branch, Research Institute , National Cancer Center, Center for Prostate Cancer, Hospital , Goyang , Gyeonggi-do , Korea.
Soo-Jeong Limd Department of Bioscience and Bioengineering , Sejong University , Seoul , Korea.
Yuh-Seog Junga Immunotherapeutics Branch , Research Institute, National Cancer Center , Goyang , Gyeonggi-do , Korea.
Hyo-Kyung Hane College of Pharmacy , Dongguk University-Seoul , Goyang , Gyeonggi-do , Korea.
Kyung-Chae Jeongf Translational Research Branch , Research Institute, National Cancer Center , Goyang , Gyeonggi-do , Korea.
Sang-Jin Leea Immunotherapeutics Branch , Research Institute, National Cancer Center , Goyang , Gyeonggi-do , Korea.
National Cancer Center · KRDongguk University · KRSejong University · KRWonkwang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a previous report, 3-aminopropyl functionalized magnesium phyllosilicate (aminoclay) improved adenovirus transduction efficiency by shielding the negative surface charges of adenovirus particles. The present study analyzed the physicochemical characterization of the electrostatic complex of adenoviruses with aminoclay and explored whether it could be utilized for enhancing tumor suppressive activity in the bladder. As a result of aminoclay-adenovirus nanobiohybridization, its transduction was enhanced in a dose-dependent manner, increasing transgene expression in bladder cancer cells and in in vivo animal models. Physicochemical studies demonstrated that positively charged aminoclay led to the neutralization of negative surface charges of adenoviruses, protection of adenoviruses from neutralizing antibodies and lowered transepithelial electrical resistance (TEER). As expected from the physicochemical properties, the aminoclay enabled tumor-targeting adenoviruses to be more potent in killing bladder cancer cells and suppressing tumor growth in orthotopic bladder tumors, suggesting that aminoclay would be an efficient, versatile and biocompatible delivery carrier for intravesical instillation of adenoviruses.

Indexed as

AdenoviridaeAdministration, IntravesicalAnimalsCell Line, TumorFemaleGenetic TherapyHumansMiceMice, Inbred C3HStatic ElectricityTransgenesUrinary BladderUrinary Bladder NeoplasmsadenovirusAminoclaybladder cancergene therapytransduction

Identifiers

PMID29224371
PMCPMC6058485
OpenAlexW2772226932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.